Ongoing monitoring isn’t just a reassurance — it changes real decisions. A rechecked panel showing a marker trending in the wrong direction can move a dosing adjustment up before it becomes a bigger issue, rather than waiting for a symptom to show up first.
It also catches the opposite: a protocol that’s already done its job. Several pilot members were tapered off a compound entirely once rechecked markers showed they no longer needed it — a call that’s only possible because someone was actually looking at the data on a schedule.